Novo Nordisk A/S vs Wix.Com Ltd — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Wix.Com Ltd trades at $53.52 (market cap $2.23B). The key difference: Novo Nordisk A/S is far larger — about 98.9× Wix.Com Ltd's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Wix.Com Ltd pays none. Which is the better fit depends on your goals.
| NVO | WIX | |
|---|---|---|
Market Cap | $220.53B | $2.23B |
Sector | Health | Technology |
52-Week High | $71.70 | $184.24 |
52-Week Low | $35.29 | $40.43 |
Enterprise Value | $239.49B | $1.80B |
Dividend Yield | 3.63% | — |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →